KCP
gene geneOn this page
Also known as FLJ33365NET67
Summary
KCP (kielin cysteine rich BMP regulator, HGNC:17585) is a protein-coding gene on chromosome 7q32.1, encoding Kielin/chordin-like protein (Q6ZWJ8). Enhances bone morphogenetic protein (BMP) signaling in a paracrine manner.
Predicted to be involved in positive regulation of BMP signaling pathway. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be located in extracellular space. Predicted to be active in extracellular region.
Source: NCBI Gene 375616 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 290 total
- MANE Select transcript:
NM_001366122
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17585 |
| Approved symbol | KCP |
| Name | kielin cysteine rich BMP regulator |
| Location | 7q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ33365, NET67 |
| Ensembl gene | ENSG00000135253 |
| Ensembl biotype | protein_coding |
| OMIM | 609344 |
| Entrez | 375616 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 6 retained_intron, 2 protein_coding, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined
ENST00000460528, ENST00000492679, ENST00000610776, ENST00000611280, ENST00000612224, ENST00000613019, ENST00000616669, ENST00000676619, ENST00000676717, ENST00000678812, ENST00000678888, ENST00000679229
RefSeq mRNA: 2 — MANE Select: NM_001366122
NM_001366122, NM_199349
CCDS: CCDS94194
Canonical transcript exons
ENST00000610776 — 40 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003712612 | 128878558 | 128878722 |
| ENSE00003712988 | 128880997 | 128881085 |
| ENSE00003713238 | 128876865 | 128877311 |
| ENSE00003714896 | 128890905 | 128891096 |
| ENSE00003714978 | 128910601 | 128910709 |
| ENSE00003715743 | 128879522 | 128879623 |
| ENSE00003715852 | 128903727 | 128903820 |
| ENSE00003717042 | 128884781 | 128884863 |
| ENSE00003717642 | 128884002 | 128884122 |
| ENSE00003717808 | 128892688 | 128892794 |
| ENSE00003718192 | 128880386 | 128880528 |
| ENSE00003718780 | 128893976 | 128894055 |
| ENSE00003719614 | 128891185 | 128891278 |
| ENSE00003721596 | 128885097 | 128885270 |
| ENSE00003725090 | 128886876 | 128886966 |
| ENSE00003726174 | 128879913 | 128880085 |
| ENSE00003726417 | 128886655 | 128886737 |
| ENSE00003727032 | 128893806 | 128893899 |
| ENSE00003727782 | 128888863 | 128889039 |
| ENSE00003729006 | 128907101 | 128907177 |
| ENSE00003729303 | 128892514 | 128892607 |
| ENSE00003730372 | 128890343 | 128890513 |
| ENSE00003732925 | 128881937 | 128882016 |
| ENSE00003734157 | 128908426 | 128908568 |
| ENSE00003734462 | 128879718 | 128879829 |
| ENSE00003736710 | 128893391 | 128893476 |
| ENSE00003738134 | 128877484 | 128877790 |
| ENSE00003738627 | 128886464 | 128886557 |
| ENSE00003739918 | 128891451 | 128891533 |
| ENSE00003743073 | 128887215 | 128887300 |
| ENSE00003745323 | 128893238 | 128893319 |
| ENSE00003745650 | 128907264 | 128907453 |
| ENSE00003746903 | 128891646 | 128891819 |
| ENSE00003748220 | 128892869 | 128893021 |
| ENSE00003748576 | 128902777 | 128902859 |
| ENSE00003748792 | 128880619 | 128880721 |
| ENSE00003750305 | 128894200 | 128894293 |
| ENSE00003751342 | 128904056 | 128904138 |
| ENSE00003752275 | 128881626 | 128881725 |
| ENSE00003752537 | 128906279 | 128906363 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 94.82.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2377 / max 112.9415, expressed in 342 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86082 | 0.6635 | 168 |
| 86083 | 0.4476 | 167 |
| 86077 | 0.0781 | 5 |
| 86081 | 0.0350 | 11 |
| 86075 | 0.0099 | 4 |
| 86076 | 0.0036 | 3 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| metanephros cortex | UBERON:0010533 | 94.82 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 92.93 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 92.91 | gold quality |
| cerebellar cortex | UBERON:0002129 | 92.81 | gold quality |
| cerebellum | UBERON:0002037 | 90.39 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.16 | gold quality |
| metanephros | UBERON:0000081 | 82.26 | gold quality |
| cortex of kidney | UBERON:0001225 | 81.98 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 81.76 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.90 | gold quality |
| pancreatic ductal cell | CL:0002079 | 76.52 | silver quality |
| kidney | UBERON:0002113 | 76.06 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.50 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.30 | gold quality |
| gastrocnemius | UBERON:0001388 | 75.23 | gold quality |
| sperm | CL:0000019 | 75.20 | silver quality |
| small intestine Peyer’s patch | UBERON:0003454 | 74.39 | gold quality |
| omental fat pad | UBERON:0010414 | 74.18 | gold quality |
| peritoneum | UBERON:0002358 | 74.13 | gold quality |
| muscle of leg | UBERON:0001383 | 74.00 | gold quality |
| esophagus mucosa | UBERON:0002469 | 73.99 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.97 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 73.24 | gold quality |
| small intestine | UBERON:0002108 | 72.66 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.64 | gold quality |
| gall bladder | UBERON:0002110 | 72.47 | gold quality |
| cortical plate | UBERON:0005343 | 71.93 | gold quality |
| secondary oocyte | CL:0000655 | 71.72 | silver quality |
| right frontal lobe | UBERON:0002810 | 69.23 | gold quality |
| mucosa of stomach | UBERON:0001199 | 68.59 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 14.89 |
| E-MTAB-9543 | yes | 5.11 |
| E-ANND-3 | yes | 4.34 |
| E-MTAB-5061 | no | 3.51 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
10 targeting KCP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-122-5P | 97.23 | 64.92 | 1024 |
Literature-anchored findings (GeneRIF, showing 2)
- The KCP was closely associated with heart failure. The regulation of BMP2/7 and TGF-beta1 expression may be the possible mechanisms. (PMID:30144436)
- Kielin/chordin-like protein enhances induction of osteoblast differentiation by Bone Morphogenetic Protein-2. (PMID:37226930)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kcp | ENSDARG00000078508 |
| mus_musculus | Kcp | ENSMUSG00000059022 |
| rattus_norvegicus | Kcp | ENSRNOG00000021855 |
Paralogs (19): CHRDL2 (ENSG00000054938), CHRD (ENSG00000090539), CHRDL1 (ENSG00000101938), TECTA (ENSG00000109927), VWF (ENSG00000110799), MUC5B (ENSG00000117983), ZAN (ENSG00000146839), CRIM1 (ENSG00000150938), BMPER (ENSG00000164619), OTOGL (ENSG00000165899), VWCE (ENSG00000167992), VWC2L (ENSG00000174453), MUC6 (ENSG00000184956), OTOG (ENSG00000188162), VWC2 (ENSG00000188730), MUC2 (ENSG00000198788), MUC19 (ENSG00000205592), MUC5AC (ENSG00000215182), FCGBP (ENSG00000275395)
Protein
Protein identifiers
Kielin/chordin-like protein — Q6ZWJ8 (reviewed: Q6ZWJ8)
Alternative names: Cysteine-rich BMP regulator 2, Cysteine-rich motor neuron 2 protein, Kielin/chordin-like protein 1
All UniProt accessions (4): A0A087WVT8, A0A087WXB2, A0A7I2V446, Q6ZWJ8
UniProt curated annotations — full annotation on UniProt →
Function. Enhances bone morphogenetic protein (BMP) signaling in a paracrine manner. In contrast, it inhibits both the activin-A and TGFB1-mediated signaling pathways.
Subunit / interactions. Interacts with BMP7 and, by doing so, enhances binding to the type I receptors that contains cytoplasmic serine/threonine protein kinase domains. Also able to interact with activin-A and TGFB1.
Subcellular location. Secreted.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZWJ8-3 | 3 | yes |
| Q6ZWJ8-2 | 2 | |
| Q6ZWJ8-4 | 4 |
RefSeq proteins (1): NP_001353051* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001007 | VWF_dom | Domain |
| IPR001846 | VWF_type-D | Domain |
| IPR014853 | VWF/SSPO/ZAN-like_Cys-rich_dom | Domain |
| IPR036084 | Ser_inhib-like_sf | Homologous_superfamily |
| IPR052424 | Kielin_Chordin-BMP_Reg | Family |
Pfam: PF00093, PF00094, PF23334
UniProt features (39 total): domain 18, splice variant 6, sequence variant 4, glycosylation site 3, disulfide bond 2, signal peptide 1, chain 1, region of interest 1, coiled-coil region 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZWJ8-F1 | 72.35 | 0.06 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 1215–1347, 1237–1388
Glycosylation sites (3): 340, 499, 1090
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 61 (showing top):
GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, HNF1_Q6, LHX3_01, SREBP1_02, GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY, NKX62_Q2, RGTTAMWNATT_HNF1_01, GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY, GROSS_HYPOXIA_VIA_ELK3_ONLY_DN, chr7q32, GOBP_RESPONSE_TO_BMP, NKX25_01, GOBP_RESPONSE_TO_GROWTH_FACTOR, GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY, HNF1_01
GO Biological Process (2): positive regulation of BMP signaling pathway (GO:0030513), hematopoietic progenitor cell differentiation (GO:0002244)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| BMP signaling pathway | 1 |
| regulation of BMP signaling pathway | 1 |
| positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1 |
| hemopoiesis | 1 |
| cell differentiation | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
454 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KCP | BMP7 | P18075 | 763 |
| KCP | LRRC8A | Q8IWT6 | 614 |
| KCP | TTYH2 | Q9BSA4 | 564 |
| KCP | LRRC8E | Q6NSJ5 | 519 |
| KCP | LRRC8D | Q7L1W4 | 510 |
| KCP | LRRC8C | Q8TDW0 | 501 |
| KCP | TTYH3 | Q9C0H2 | 472 |
| KCP | TTYH1 | Q9H313 | 461 |
| KCP | CHRD | Q9H2X0 | 416 |
| KCP | TGFA | P01135 | 408 |
| KCP | LRRC8B | Q6P9F7 | 399 |
| KCP | CNNM1 | Q9NRU3 | 380 |
| KCP | TMEM205 | Q6UW68 | 356 |
| KCP | STARD9 | Q9P2P6 | 349 |
| KCP | MLANA | Q16655 | 349 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2VEC9, O08644, O08852, O15197, O55225, O88839, O95428, O97507, P00748, P07204, P0C0K6, P0C0K7, P15306, P26010, P26011, P60882, P98140, P98167, Q00657, Q04912, Q04962, Q0V8J4, Q13444, Q2PC93, Q3U492, Q4G0T1, Q5IJ48, Q6GUQ1, Q6MG64, Q6MG84, Q6UVK1, Q6ZRI0, Q6ZWJ8, Q700K0, Q71U07, Q769J6, Q76LX8, Q7Z7M0, Q80YA8, Q8CG65
Diamond homologs: A2VEC9, A6QNY1, B3EWZ3, B3EWZ8, C0HL12, C5IAW9, D3YXG0, D3ZTD8, F1LW30, O08721, O08722, O08747, O14514, O15072, O55225, O60241, O60242, O75173, O88783, O95185, O95450, P04275, P07358, P07996, P27918, P35441, P35442, P35448, P55314, P57110, P58397, P58459, P59384, P79331, P80012, P97857, P98088, P98092, P98160, P98164
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
290 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 251 |
| Likely benign | 22 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
6705 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:128865372:CACA:C | acceptor_loss | 1.0000 |
| 7:128865374:CA:C | acceptor_loss | 1.0000 |
| 7:128865375:A:AG | acceptor_gain | 1.0000 |
| 7:128865375:A:AT | acceptor_loss | 1.0000 |
| 7:128865376:G:GG | acceptor_gain | 1.0000 |
| 7:128865376:GGCA:G | acceptor_gain | 1.0000 |
| 7:128865376:GGCAA:G | acceptor_gain | 1.0000 |
| 7:128879518:GCA:G | donor_loss | 1.0000 |
| 7:128879520:A:AT | donor_loss | 1.0000 |
| 7:128879712:GCTCA:G | donor_loss | 1.0000 |
| 7:128879714:TCA:T | donor_loss | 1.0000 |
| 7:128879715:CA:C | donor_loss | 1.0000 |
| 7:128879716:A:AC | donor_gain | 1.0000 |
| 7:128879716:A:C | donor_loss | 1.0000 |
| 7:128879717:C:CC | donor_gain | 1.0000 |
| 7:128879731:T:TA | donor_gain | 1.0000 |
| 7:128879825:GCACA:G | acceptor_gain | 1.0000 |
| 7:128879826:CACA:C | acceptor_gain | 1.0000 |
| 7:128879826:CACAC:C | acceptor_gain | 1.0000 |
| 7:128879827:ACA:A | acceptor_gain | 1.0000 |
| 7:128879828:CA:C | acceptor_gain | 1.0000 |
| 7:128879828:CAC:C | acceptor_gain | 1.0000 |
| 7:128879830:C:CC | acceptor_gain | 1.0000 |
| 7:128880385:CGGGG:C | donor_gain | 1.0000 |
| 7:128880995:A:AC | donor_gain | 1.0000 |
| 7:128880996:C:CC | donor_gain | 1.0000 |
| 7:128891735:T:A | donor_gain | 1.0000 |
| 7:128892510:ATAC:A | donor_loss | 1.0000 |
| 7:128892512:A:C | donor_loss | 1.0000 |
| 7:128892513:CCT:C | donor_loss | 1.0000 |
AlphaMissense
10573 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:128891491:A:C | F617C | 0.996 |
| 7:128892978:C:A | W441C | 0.996 |
| 7:128892978:C:G | W441C | 0.996 |
| 7:128888997:A:C | F797C | 0.995 |
| 7:128879967:A:C | F1233C | 0.991 |
| 7:128892997:A:C | F435C | 0.991 |
| 7:128878561:C:A | W1376C | 0.990 |
| 7:128878561:C:G | W1376C | 0.990 |
| 7:128885227:C:A | W974C | 0.990 |
| 7:128885227:C:G | W974C | 0.990 |
| 7:128877687:C:G | C1412S | 0.988 |
| 7:128877688:A:T | C1412S | 0.988 |
| 7:128879966:G:C | F1233L | 0.987 |
| 7:128879966:G:T | F1233L | 0.987 |
| 7:128879968:A:G | F1233L | 0.987 |
| 7:128879967:A:G | F1233S | 0.986 |
| 7:128892728:A:C | F500C | 0.986 |
| 7:128884821:A:C | F1032C | 0.985 |
| 7:128891490:G:C | F617L | 0.985 |
| 7:128891490:G:T | F617L | 0.985 |
| 7:128891491:A:G | F617S | 0.985 |
| 7:128891492:A:G | F617L | 0.985 |
| 7:128877503:C:A | W1473C | 0.984 |
| 7:128877503:C:G | W1473C | 0.984 |
| 7:128880473:C:A | W1164C | 0.984 |
| 7:128880473:C:G | W1164C | 0.984 |
| 7:128888996:G:C | F797L | 0.984 |
| 7:128888996:G:T | F797L | 0.984 |
| 7:128888998:A:G | F797L | 0.984 |
| 7:128888997:A:G | F797S | 0.981 |
dbSNP variants (sampled 300 via entrez): RS1000137428 (7:128909526 C>T), RS1000341189 (7:128903954 G>A), RS1000403868 (7:128890267 C>A,T), RS1000440640 (7:128897468 TTG>T), RS1000662463 (7:128901767 C>T), RS1000680947 (7:128878287 A>C,G,T), RS1000752859 (7:128878615 C>A,T), RS1000943480 (7:128900713 G>A,C), RS1001007548 (7:128893429 G>A,C), RS1001023687 (7:128879552 A>C,G,T), RS1001065636 (7:128887680 CACAT>C,CACATACAT), RS1001081908 (7:128884801 A>C,G), RS1001203153 (7:128910865 A>G), RS1001306233 (7:128910112 G>A,T), RS1001355323 (7:128893114 G>A,C)
Disease associations
OMIM: gene MIM:609344 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009597_34 | Multiple sclerosis | 3.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression, increases methylation | 3 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Cadmium Chloride | increases expression | 2 |
| bisphenol A | decreases methylation | 1 |
| arsenite | increases methylation | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| nutlin 3 | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Glyphosate | affects methylation | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dactinomycin | affects cotreatment, increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Epichlorohydrin | affects response to substance | 1 |
| Formaldehyde | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Gold Compounds | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.